Related Experiment Video
Updated: Jul 2, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Structural differences among cost-effectiveness models of human papillomavirus vaccines
Ralph P Insinga1, Erik J Dasbach, Elamin H Elbasha
1Department of Health Economic Statistics, Merck Research Laboratories, North Wales, PA 19454-1099, USA. ralph_insinga@merck.com
Expert Review of Vaccines
|September 5, 2008
Summary
Cost-effectiveness studies for human papillomavirus (HPV) vaccines show significant variation in assumptions. Key uncertainties in HPV vaccine modeling may lead to underestimating their true cost-effectiveness.
Area of Science:
- Public Health
- Health Economics
- Epidemiology
Background:
- Human papillomavirus (HPV) infection is a major cause of cervical cancer.
- HPV vaccines have been developed to prevent HPV-related diseases.
- Cost-effectiveness analyses are crucial for guiding vaccination policies.
Purpose of the Study:
- To compare structural assumptions in published HPV vaccine cost-effectiveness studies.
- To critically review these assumptions and their impact on study results.
- To identify key areas of uncertainty affecting HPV vaccine cost-effectiveness.
Main Methods:
- Systematic review of existing cost-effectiveness studies on HPV vaccines.
- Analysis of structural assumptions related to HPV infection, disease, screening, and vaccination.
- Critical evaluation of the influence of these assumptions on model outcomes.
Main Results:
- Considerable variation exists in influential assumptions across HPV vaccine cost-effectiveness models.
- Assumptions regarding vaccine protection duration and HPV immunity are significant sources of uncertainty.
- The combined impact of current assumptions may underestimate the cost-effectiveness of HPV vaccination.
Conclusions:
- Variability in model assumptions complicates precise estimation of HPV vaccine cost-effectiveness.
- Further research is needed to address uncertainties in vaccine protection and HPV natural immunity.
- Rigorous evaluation of existing modeling results is necessary due to identified limitations.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:51Vaccinations
Overview
01:25Models of Health Promotion and Illness Prevention I
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...